Back to top

marijuana: Archive

Aparajita Dutta

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism.

MJPositive Net Change TLRYNegative Net Change YOLOPositive Net Change CNBSPositive Net Change MSOSPositive Net Change WEEDPositive Net Change

Sundeep Ganoria

Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch

Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.

CGCPositive Net Change TLRYNegative Net Change VFFPositive Net Change

Sundeep Ganoria

Here's Why JAZZ Stock Is an Unconventional Cannabis Investment

Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.

JAZZNegative Net Change ACBPositive Net Change GTBIFPositive Net Change

Sundeep Ganoria

Green Thumb Launches $50M Buyback: Time to Get Bullish on the Stock?

GTBIF launches a $50 million share buyback program, signaling confidence in long-term growth despite market and pricing pressures.

TLRYNegative Net Change GTBIFPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?

CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.

TLRYNegative Net Change GTBIFPositive Net Change CRLBFPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

Cannabis Stock CRON Trades Near 52-Week High: How to Play

Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.

CRONNegative Net Change TLRYNegative Net Change HITIPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?

Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.

ACBPositive Net Change GTBIFPositive Net Change VRNOFPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

3 Cannabis Stocks to Watch After Trump's Marijuana Rescheduling Signal

Trump's marijuana rescheduling remarks reignite cannabis optimism, putting Village Farms, Canopy Growth and High Tide in focus.

CGCPositive Net Change VFFPositive Net Change HITIPositive Net Change

Sweta Killa

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.

MJPositive Net Change CGCPositive Net Change TLRYNegative Net Change ACBPositive Net Change YOLOPositive Net Change CNBSPositive Net Change MSOSPositive Net Change WEEDPositive Net Change

Sundeep Ganoria

Can Cannabis Stocks Reverse Their Prolonged Downtrend?

Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.

CRBPNegative Net Change CGCPositive Net Change TLRYNegative Net Change HRMYNegative Net Change GTBIFPositive Net Change

Sundeep Ganoria

Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?

Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.

CGCPositive Net Change TLRYNegative Net Change ACBPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

Cannabis Operator CRLBF Plans California Exit: How to Play the Stock?

Cresco plans to exit California, citing tough market dynamics, as it sharpens focus on high-margin growth markets.

TLRYNegative Net Change GTBIFPositive Net Change CRLBFPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

Cannabis Operator Green Thumb Down 30% YTD: Time to Buy, Sell or Hold?

GTBIF slides 30% YTD as rising costs, flat revenues and tight U.S. rules weigh on margins and investor sentiment.

ACBPositive Net Change GTBIFPositive Net Change CRLBFPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

Cannabis Stock Cresco Labs Plunges 24% YTD: Time to Sell or Hold?

CRLBF is down 24% YTD as U.S.-only exposure, falling margins and tighter regulations weigh on its cannabis business.

CGCPositive Net Change TLRYNegative Net Change ACBPositive Net Change CRLBFPositive Net Change

Sundeep Ganoria

Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment

HRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.

JAZZNegative Net Change AXSMNegative Net Change HRMYNegative Net Change

Sundeep Ganoria

Cannabis Operator Curaleaf Plunges 46% YTD: Time to Sell or Hold?

CURLF dives 46% YTD as domestic headwinds outweigh global growth; is it time to cash out or wait for a rebound?

CGCPositive Net Change TLRYNegative Net Change ACBPositive Net Change CURLFPositive Net Change

Sundeep Ganoria

Could the New Federal Bill Derail the U.S. Hemp Industry?

A proposed federal bill could upend the U.S. hemp market, threatening CBD and Delta-8 products now sold nationwide.

CGCPositive Net Change TLRYNegative Net Change CURLFPositive Net Change

Sundeep Ganoria

Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell?

Canopy Growth surges 39% in three months as restructuring, margin gains and debt cuts renew investor interest.

CGCPositive Net Change TLRYNegative Net Change ACBPositive Net Change VFFPositive Net Change

Sundeep Ganoria

Cannabis Operator VFF Sells Fresh Produce Unit: How to Play the Stock?

After dropping its produce business, Village Farms sharpens its cannabis focus - boosting exports, margins and market share.

CGCPositive Net Change TLRYNegative Net Change ACBPositive Net Change VFFPositive Net Change

Sundeep Ganoria

Aurora Cannabis Stock Rises 30% YTD: Time to Buy or Sell?

ACB's 30% YTD rally reflects Q3 strength, but flat EPS estimates and consumer weakness keep analysts cautious about long-term upside.

CGCPositive Net Change TLRYNegative Net Change ACBPositive Net Change

Sundeep Ganoria

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies

NVO, CRBP and SKYE are tapping into the booming obesity market with novel CBD-based therapies, offering alternatives amid intensifying GLP-1 competition.

NVOPositive Net Change LLYPositive Net Change CRBPNegative Net Change SKYENegative Net Change

Sundeep Ganoria

Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?

While CRBP's pipeline shows promise, the company's lack of marketed products remains a concern.

SNYNegative Net Change NVOPositive Net Change CRBPNegative Net Change

Sundeep Ganoria

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold?

TLRY's pivot into beverages shows promise, but with falling cannabis sales and delisting risks, we recommend staying on the sidelines for now.

PMPositive Net Change JAZZNegative Net Change CRBPNegative Net Change TLRYNegative Net Change

Zacks Equity Research

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook

Jazz reports dismal first-quarter results. The company revises its 2025 EPS guidance to account for the recently completed Chimerix acquisition.

JAZZNegative Net Change PBYINegative Net Change NTLAPositive Net Change

Zacks Equity Research

IIPR's Q1 Earnings Coming Up: Key Factors to Impact the Stock

IIPR's Q1 2025 results may be impacted by property repossessions/sales, rent deferrals and partial tenant payments.

IIPRNegative Net Change LAMRNegative Net Change EPRNegative Net Change